Health Newsfeed – Johns Hopkins Medicine Podcasts

Breathlessness clinic is a new approach at Johns Hopkins to assist people with chronic lung diseases to live their best lives with these often debilitating conditions. Anna Gersten, a lung expert and director of the clinic, explains who would benefit. …

Who is suitable for a breathlessness clinic visit? Elizabeth Tracey reports Read more →

Being short of breath is a terrible feeling, most people agree, and it’s a feature of many lung diseases, especially as they progress. Lung expert Anna Gersten at Johns Hopkins describes how a breathlessness clinic came to be at Hopkins …

What is a breathlessness clinic? Elizabeth Tracey reports Read more →

High blood biomarkers for Alzheimer’s disease found by the newly FDA approved blood test indicate the presence of two proteins in the brain called amyloid and tau. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says some …

What are current studies doing when high levels of blood biomarkers for Alzheimer’s are found? Elizabeth Tracey reports Read more →

Let’s say you’ve taken the newly approved blood test for Alzheimer’s disease and the results indicate the presence of tau and amyloid in your brain, so you’re at risk.  Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says …

What are your options if a new blood test says you are at risk for Alzheimer’s disease? Elizabeth Tracey reports Read more →

You may have heard of a new blood test for Alzheimer’s disease just approved by the FDA. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says even if you are older and have symptoms of the disease, …

People who develop dementia as they age most often have a mixed type, Elizabeth Tracey reports Read more →

A new blood test for Alzheimer’s disease isn’t a stand alone diagnostic tool. That’s according to Abhay Moghekar, a blood biomarkers expert and a neurologist at Johns Hopkins. Moghekar: You would still need the clinical input in the context of …

A truly comprehensive test for Alzheimer’s disease may be on the horizon, Elizabeth Tracey reports Read more →

Will an FDA cleared blood test for Alzheimer’s disease ease or complicate diagnosis? Clearly in approving the test the FDA hopes for the former, yet the complete picture is more complex than that, says Abhay Moghekar, a blood biomarkers expert …

Biomarkers alone don’t mean Alzheimer’s disease is present, Elizabeth Tracey reports Read more →

Positive results on the newly FDA cleared blood test for Alzheimer’s disease don’t necessarily mean you have the disease. That’s according to blood biomarkers expert Abhay Moghekar, a neurologist at Johns Hopkins. Moghekar: Whether that's the cause of your cognitive …

If you get a positive result on the new blood test for Alzheimer’s disease, what does that mean? Elizabeth Tracey reports Read more →

The FDA has just cleared a blood test to help make the diagnosis of Alzheimer’s disease, which otherwise may require some fairly invasive methods. Blood biomarkers expert Abhay Moghekar, a neurologist at Johns Hopkins, says the test looks for the …

Who is a candidate for the new blood test for Alzheimer’s disease? Elizabeth Tracey reports Read more →

A blood test to screen for proteins related to Alzheimer’s disease has been cleared by the FDA, and it’s designed for people who are older than 55 years of age and have cognitive symptoms. Johns Hopkins neurologist Abhay Moghekar, a …

What’s the basis of the new blood test to screen for Alzheimer’s disease? Elizabeth Tracey reports Read more →